|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 79.74 EUR | +1.40% |
|
-5.93% | +18.72% |
| 08-05 | Argus Research Adjusts Ventas Price Target to $98 From $92 | MT |
| 08-04 | Citigroup Adjusts Price Target on Ventas to $110 From $100, Maintains Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VENTAS, INC. | Healthcare REITs | +1.63% | -5.93% | +18.72% | +34.73% | +55.73% | 47.46B |
-
|
-
|
-
|
- Stock Market
- Stocks
- VTR Stock
- VEN Stock
- Charts Ventas, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
